APA

Hermiller J. B., Rutledge D. R., Gruberg L., Katopodis J. N., Lombardi W., Mao V. W., Zhao W., Sharma S. K., Tamboli H. P., Wang J., Jonnavithula L., Sudhir K. & Krucoff M. W. (20131217). Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study. : Journal of interventional cardiology.

Chicago

Hermiller James B, Rutledge David R, Gruberg Luis, Katopodis John N, Lombardi William, Mao Vivian W, Zhao Weiying, Sharma Samin K, Tamboli Hoshedar P, Wang Jin, Jonnavithula Lalitha, Sudhir Krishnankutty and Krucoff Mitchell W. 20131217. Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study. : Journal of interventional cardiology.

Harvard

Hermiller J. B., Rutledge D. R., Gruberg L., Katopodis J. N., Lombardi W., Mao V. W., Zhao W., Sharma S. K., Tamboli H. P., Wang J., Jonnavithula L., Sudhir K. and Krucoff M. W. (20131217). Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study. : Journal of interventional cardiology.

MLA

Hermiller James B, Rutledge David R, Gruberg Luis, Katopodis John N, Lombardi William, Mao Vivian W, Zhao Weiying, Sharma Samin K, Tamboli Hoshedar P, Wang Jin, Jonnavithula Lalitha, Sudhir Krishnankutty and Krucoff Mitchell W. Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study. : Journal of interventional cardiology. 20131217.